Therefore, human whole cell granulocyte macrophage colony-stimulating factor (GM-CSF) secreting pancreatic cancer vaccines (GVAX) are being developed to increase PD-L1 expression and enhance tumour antigen-specific interferon-γ producing T cells in peripheral lymphocytes. The gene discussed is CSF2; the disease is pancreatic neoplasm.